Thomas C. Freyman is the retired Executive Vice President, Finance and Administration of Abbott Laboratories, where he served as Chief Financial Officer beginning in 2001 and retired in 2017. He joined AbbVie's board in 2020 after serving as a director of Allergan from 2018 until AbbVie's acquisition of Allergan plc. Mr. Freyman chairs the Nominations & Governance committee and serves on the Compensation committee. He previously served as a director of Tenneco Inc. from 2013 to 2022 and Hanger, Inc. from 2017 to 2022.